Loading clinical trials...
Loading clinical trials...
The Physiology of Glucagon-like-peptide-1 Espression in Patients With Endogenous Hyperinsulinism: Correlation With Histopathology
Conditions
Interventions
68Ga-exendin-4 PET/CT
Locations
1
Netherlands
Radboudumc
Nijmegen, Netherlands
Start Date
February 7, 2018
Primary Completion Date
February 1, 2019
Completion Date
February 1, 2019
Last Updated
December 7, 2018
NCT02021604
NCT04538989
NCT00674440
NCT01468454
NCT03042416
NCT03053284
Lead Sponsor
Radboud University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions